Sage Journals: Discover world-class research

Open access

Review article

First published 2021

BRAF,MEK and EGFR inhibition as treatment strategies in BRAF V600E metastatic colorectal cancer

Javier Ros, Iosune Baraibar, Emilia Sardo [...]

Therapeutic Advances in Medical Oncology

Open access

Review article

First published 2022

Neoadjuvant therapy for melanoma: rationale for neoadjuvant therapy and pivotal clinical trials

Russell G. Witt, Derek J. Erstad, Jennifer A. Wargo

Therapeutic Advances in Medical Oncology

Free access

Review article

First published 2015-3

Blinded by the light: why the treatment of metastatic melanoma has created a new paradigm for the management of cancer

Colin R. Lindsay, Pavlina Spiliopoulou, Ashita Waterston

Therapeutic Advances in Medical Oncology

Open access

Case report

First published 2019

Cobimetinib- and vemurafenib-induced granulomatous dermatitis and erythema induratum: A case report

Marco AJ Iafolla, Jennifer Ramsay, Judy Wismer [...]

Sage Open Medical Case Reports

Retricted access

Case report

First published 2016-11

Exclusion Criteria vs Reality: Dual BRAF /MEK Inhibition and Radiotherapy in a Patient with Melanoma Metastatic to the Brain and ECOG 3

Iván Márquez-Rodas, Jose-Antonio Avilés-Izquierdo, Verónica Parra [...]

Tumori Journal

Open access

Review article

First published 2018

Dabrafenib in combination with trametinib in the treatment of patients with BRAF V600-positive advanced or metastatic non-small cell lung cancer: clinical evidence and experience

Arjun Khunger, Monica Khunger, Vamsidhar Velcheti

Therapeutic Advances in Respiratory Disease

Retricted access

Research article

First published 2023-10

Combination BRAF V600E Inhibition with the Multitargeting Tyrosine Kinase Inhibitor Axitinib Shows Additive Anticancer Activity in BRAF V600E -Mutant Anaplastic Thyroid Cancer

Viswanath Gunda, Chandrayee Ghosh, Jiangnan Hu [...]

Thyroid®

Free access

Review article

First published 2016-1

Combination therapy with BRAF and MEK inhibitors for melanoma: latest evidence and place in therapy

Zeynep Eroglu, Antoni Ribas

Therapeutic Advances in Medical Oncology

Retricted access

Case report

First published 2025-6

Case report: Drug-induced vitiligo during treatment with BRAF/MEK inhibitors in a patient with metastatic conjunctival melanoma

Seray Saray, Pelin Hızlı

Journal of Oncology Pharmacy Practice

Retricted access

Review article

First published 2025-10

BRAF inhibitors with or without MEK inhibitors in advanced BRAF-positive non-small cell lung cancer: A systematic review

Animesh Saha, T Raja, Amit Dutt Dwary [...]

Journal of Oncology Pharmacy Practice

Search results